3-hydroxyphenyltrimethylammonium has been researched along with Thyroid Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ailles, LE; Cao, J; Kashat, L; Macmillan, C; Masui, O; Meng, X; Ralhan, R; Siu, KW; So, AK; Walfish, PG; Wang, XS | 1 |
1 other study(ies) available for 3-hydroxyphenyltrimethylammonium and Thyroid Neoplasms
| Article | Year |
|---|---|
Secretome-based identification and characterization of potential biomarkers in thyroid cancer.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Clusterin; Cysteine-Rich Protein 61; DNA-Binding Proteins; Humans; Mice; Mice, SCID; Neoplasm Proteins; Nucleolin; Phosphoproteins; Phosphopyruvate Hydratase; Proteomics; Quaternary Ammonium Compounds; RNA-Binding Proteins; Thyroid Neoplasms; Transplantation, Heterologous; Tumor Suppressor Proteins | 2010 |